Research Notes: A Deep Dive On SKIN

SKIN has bounced sharply after a post-earnings plunge

Highlights:

• Beauty Health (SKIN) is a former high-flying de-SPAC whose 2023 performance has disappointed.

• External factors and execution are mainly to blame. Demand for the underlying product remains reasonably healthy.

• In that context, a 120% rally following a 66% post-earnings decline makes some sense — and might leave more upside ahead.